Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-SREBP2 Provides a Mechanism for Dynamic Control of Cellular Cholesterol Homeostasis.

Cells·2024
Same author

Eupatilin improves cilia defects in human CEP290 ciliopathy models.

bioRxiv : the preprint server for biology·2023
Same author

The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas.

Endocrine-related cancer·2022
Same author

Mechanical loading inhibits cartilage inflammatory signalling via an HDAC6 and IFT-dependent mechanism regulating primary cilia elongation.

Osteoarthritis and cartilage·2019
Same author

The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review.

Lupus·2018
Same author

A novel missense mutation in HSF4 causes autosomal-dominant congenital lamellar cataract in a British family.

Eye (London, England)·2017

Related Experiment Video

Updated: Jul 15, 2026

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of

J L Howarth1, S Kelly, M P Keasey

  • 1Henry Wellcome Laboratories for Integrated Neuroscience and Endocrinology, University of Bristol, Bristol, UK.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|April 12, 2007
PubMed
Summary

Heat shock protein 70 (HSP70) and DnaJ-like-1 (HSJ1) proteins reduce toxic protein inclusions in polyglutamine diseases. HSJ1 proteins enhance protein degradation via the ubiquitin-proteasome system, offering a potential therapeutic strategy.

More Related Videos

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
08:44

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

Purification of Hsp104, a Protein Disaggregase
07:17

Purification of Hsp104, a Protein Disaggregase

Published on: September 30, 2011

Related Experiment Videos

Last Updated: Jul 15, 2026

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
08:44

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

Purification of Hsp104, a Protein Disaggregase
07:17

Purification of Hsp104, a Protein Disaggregase

Published on: September 30, 2011

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Polyglutamine diseases, such as spinal and bulbar muscular atrophy (SBMA), are characterized by the formation of toxic protein inclusions.
  • Heat shock proteins (HSPs) are known to play roles in protein folding and degradation.

Purpose of the Study:

  • To investigate the efficacy of Heat Shock Protein 70 (HSP70) and DnaJ-like-1 (HSJ1) proteins in reducing polyglutamine-mediated protein inclusion formation.
  • To elucidate the mechanisms by which HSJ1 proteins affect protein aggregation and degradation.

Main Methods:

  • Expression of HSJ1 proteins, HSP70, and HSP40 in cellular and in vivo models of polyglutamine disease.
  • Assays to measure protein inclusion formation and protein degradation.
  • Analysis of ubiquitylation levels and protein complex association.

Main Results:

  • HSP70 and HSP40 reduced inclusion formation by promoting chaperone-mediated refolding.
  • HSJ1 proteins (HSJ1a and HSJ1b) significantly reduced protein inclusion formation in SBMA and neuronal models.
  • HSJ1 proteins increased target protein degradation via the ubiquitin-proteasome system (UPS), independent of chaperone activity.
  • HSJ1a expression reduced inclusions in an in vivo model of polyglutamine disease.

Conclusions:

  • HSJ1 proteins facilitate the degradation of misfolded proteins through the UPS.
  • Targeting the UPS for enhanced degradation of misfolded proteins is a promising therapeutic strategy for polyglutamine diseases.